Stem Cell Therapy Market worth $330 Million in 2020 Stem Cell Therapy Market worth $330 Million in 202 | Page 12

Stem Cell Therapy Market PH 2438 – Regulatory Landscape, Pipeline Analysis, & Global Forecasts to 2020 3.3 3.4 3.5 3.6 3.7 RESTRAINTS 3.3.1 LACK OF REQUIRED INFRASTRUCTURE 3.3.2 DIFFICULTIES RELATED WITH THE PRESERVATION OF STEM CELLS 3.3.3 ETHICAL ISSUES RELATED TO EMBRYONIC STEM (ES) CELLS 3.3.4 IMMUNOREJECTION AFTER STEM CELL TRANSPLANTATION 3.3.5 COMPLEXITIES INVOLVED IN IDENTIFICATION OF STEM CELLS IN ADULT TISSUES OPPORTUNITIES 3.4.1 LACK OF EFFECTIVE TREATMENTS TO CURE DISEASES 3.4.2 EVOLUTION OF NEW STEM CELL THERAPIES 3.4.3 EMERGENCE OF INDUCED PLURIPOTENT STEM (IPS) CELLS AS AN ALTERNATIVE TO ESC 3.4.4 EMERGING MARKETS UNFOLD NEW AVENUES DUE TO LOW REGULATORY BARRIERS AND CLINICAL TRIAL COSTS CHALLENGES 3.5.1 DEARTH OF REIMBURSEMENTS 3.5.2 HIGH COSTS INCURRED IN STEM CELL PROCESSING 3.5.3 NEED OF AUTOMATED CELL CULTURING 3.5.4 LACK OF CLEAR REGULATORY GUIDELINES WINNING IMPERATIVES 3.6.1 PARTNERING WITH ACADEMIC INSTITUTES 3.6.2 COLLABORATING WITH GIANT PHARMACEUTICAL FIRMS 3.6.3 HIGH FOCUS ON EMERGING MARKETS BURNING ISSUES 3.7.1 ESTABLISHMENT OF SAFETY PROFILES FOR STEM CELL THERAPY 3.7.2 GRANTING ORPHAN DRUG STATUS TO STEM CELL THERAPEUTICS [email protected] www.marketsandmarkets.com 12